BGLAP and type 2 diabetes mellitus: The model suggests molecular targets such as adiponectin, growth hormone, melatonin and testosterone for prevention of T2DM; and dopamine, ghrelin, oestrogen and osteocalcin for prevention as well as treatment of T2DM.